Sign In
Buy SNY
$43.75
-0.230 (-0.523%)
At Close: Jul 21, 2026
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
11:26am, Monday, 13'th May 2024
Sanofi (SNY) and Regeneron's (REGN) Dupixent is poised to be the first medicine for adolescents with inadequately controlled CRSwNP, if approved by the FDA.
Sanofi pledges new 1 bln euros worth of investments in French production sites
01:15am, Monday, 13'th May 2024
Sanofi on Monday announced it would invest over 1 billion euros ($1.1 billion) to create new medicines and vaccine production capacities at three of its French sites.
Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereignty Paris, May 13, 2024. As the largest private contribu
Novavax: Sanofi Partnership Revitalizes My Magnum Opus
01:07pm, Sunday, 12'th May 2024
Novavax announced Q1 2024 results with a beat on EPS and a miss on revenue, causing a surge in premarket trading. Novavax finalized a licensing agreement with Sanofi worth up to $1.2B, boosting its CO
Novavax Surges on $1.2 Billion Sanofi Vaccine Deal
01:20pm, Friday, 10'th May 2024
Novavax shares soared after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid-19 and flu shot. Madison Muller reports on Bloomberg Televi
Novavax shares skyrocket after billion-dollar licensing deal with Sanofi
12:24pm, Friday, 10'th May 2024
Novavax, Inc. (NASDAQ:NVAX) shares surged Friday following the announcement of a significant licensing agreement with Sanofi SA (ADR) (NYSE:SNY), valued at $1.2 billion. The deal encompasses the comme
Novavax (NVAX) Deal with Sanofi to Co-Commercialize Covid Vaccine
12:14pm, Friday, 10'th May 2024
Novavax (NVAX) signed a deal with drugmaker Sanofi to co-commercialize the Covid Vaccine. Diane King Hall discusses this, as well as Novavax's 1Q earnings.
Novavax stock soars on $1.2 billion Sanofi vaccine deal
11:58am, Friday, 10'th May 2024
Novavax (NVAX) shares are skyrocketing after announcing a $1.2 billion deal with Sanofi (SNY) to commercialize a combined COVID-19 and flu shot. Yahoo Finance's Anjalee Khemlani joins The Morning Brie
Novavax Stock Doubles on $1.2B Sanofi Deal for COVID-19, Flu Vaccines
10:45am, Friday, 10'th May 2024
Novavax (NVAX) shares more than doubled in intraday trading Friday after announcing a $1.2 billion deal to license its vaccine technology to French drugmaker Sanofi (SNY).
Vaccine Stock Explodes After Sanofi Deal
10:07am, Friday, 10'th May 2024
Novavax Inc (NASDAQ:NVAX) stock is up 130% to trade at $10.82 today, by far the best stock on the Nasdaq this morning.
Novavax Gets $1.4 Billion Deal With Sanofi. The Stock Jumps.
06:47am, Friday, 10'th May 2024
The two companies will also work on a shot that combines Covid-19 and flu vaccines.
3 Biotech Stocks to Sell in May Before They Crash & Burn
06:30am, Friday, 10'th May 2024
Although 5% up over one year, the S&P Biotechnology Select Industry Index is down .22% year-to-date. This seems to be a normalization period.
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses
05:53am, Friday, 10'th May 2024
Novavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the company's fiscal Q1 2024 earnings report but more significantly, by a crucial multi-billion dollar deal wi
Novavax shares surge on new $1.4 billion deal with Sanofi
05:00am, Friday, 10'th May 2024
Novavax on Friday said it had struck a $1.4 billion deal with Sanofi to commercialize its existing COVID-19 vaccine and develop a new combined jab to inoculate against both the coronavirus and influen
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
02:15am, Friday, 10'th May 2024
Announces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing Novavax's
